CISSVSGTBP• 28 Days (Normalized)
CISS vs GTBP (C3is Inc. vs GT Biopharma Inc.)
Showing Closing Date Range from Aug 28 to Sep 25, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
CISS Performance $1.1
-39.5%
C3is Inc.
Normalized Baseline0.00%
GTBP Performance $7.1
+%
GT Biopharma Inc.
Normalized Baseline0.00%
Alpha Spread Margin GTBP LEADS
-39.5 pts
GTBP outperforming by 39.50 percentage points
CISSGTBP
Spread Trajectory28 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
CISS GTBP
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(20 dates)
| Date | CISS Price | CISS Gain (%) | GTBP Price | GTBP Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 25, 2026 | $1.10 | -39.50% | $- | - | |
| Sep 24, 2026 | $1.12 | -38.12% | $- | - | |
| Sep 23, 2026 | $1.10 | -39.23% | $7.10 | +2266.67% | -2305.90% |
| Sep 22, 2026 | $1.14 | -37.02% | $- | - | |
| Sep 21, 2026 | $1.23 | -32.04% | $7.18 | +2293.33% | -2325.37% |
| Sep 18, 2026 | $1.29 | -28.73% | $7.16 | +2286.67% | -2315.40% |
| Sep 17, 2026 | $1.33 | -26.52% | $7.49 | +2396.67% | -2423.19% |
| Sep 16, 2026 | $1.24 | -31.49% | $7.81 | +2503.33% | -2534.82% |
| Sep 15, 2026 | $1.25 | -30.94% | $9.00 | +2900.00% | -2930.94% |
| Sep 14, 2026 | $1.37 | -24.31% | $11.63 | +3776.67% | -3800.98% |
| Sep 11, 2026 | $1.37 | -24.31% | $8.61 | +2770.00% | -2794.31% |
| Sep 10, 2026 | $1.45 | -19.89% | $6.18 | +1960.00% | -1979.89% |
| Sep 09, 2026 | $1.42 | -21.55% | $5.98 | +1893.33% | -1914.88% |
| Sep 08, 2026 | $1.46 | -19.34% | $- | - | |
| Sep 04, 2026 | $1.49 | -17.68% | $0.24 | -19.67% | +1.99% |
Page 1 of 2